Eam Global Investors LLC Bio Xcel Therapeutics, Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$37.44 - $64.63 $1.41 Million - $2.44 Million
-37,777 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$17.62 - $58.71 $600,154 - $2 Million
-34,061 Reduced 47.41%
37,777 $2 Million
Q1 2020

May 13, 2020
BUY
$12.26 - $41.14 $880,733 - $2.96 Million
71,838 New
71,838 $1.61 Million

Others Institutions Holding BTAI

# of Institutions
51
Shares Held
3.11M
Call Options Held
22.2K
Put Options Held
40.2K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $9.25M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email